{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:04:56Z","timestamp":1791140696948,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:p>The novel marker special AT-rich sequence binding protein (SATB2) is highly sensitive for mesenchymal tumors with osteoblastic differentiation. However, SATB2 expression in gynecologic tract carcinosarcoma has not been previously explored. Given the potential prognostic and therapeutic implications of heterologous carcinosarcoma in the gynecologic tract, this study investigates the utility of SATB2 in identifying osteosarcomatous elements. A multi-institution database review identified consecutive cases of gynecologic tract carcinosarcoma including both heterologous and homologous types. Clinicopathologic parameters were recorded. Nuclear SATB2 immunoreactivity was scored from 1 representative whole-slide section from each case. Sixty gynecologic tract carcinosarcoma were identified (uterine corpus=47, ovary=11, fallopian tube=1, cervix=1) including 32 heterologous type (7 osteosarcoma, 3 mixed osteosarcoma\/chondrosarcoma, 6 chondrosarcoma, 12 rhabdomyosarcoma, 4 mixed chondrosarcoma\/rhabdomyosarcoma) and 28 homologous type. Patient ages ranged from 41 to 90 yr (average 67.9 yr). Mostly diffuse strong SATB2 positivity was present in 10\/10 (100%) cases containing osteosarcoma. In these cases, SATB2 positivity was seen in malignant cells intimately associated with osteoid or bone [3\/10 (30%) of these cases additionally showed patchy weak\/moderate SATB2 staining in areas of nonosteogenic sarcoma elsewhere in the same tumor]. SATB2 positivity was present in 30\/50 (60%) cases lacking osteosarcoma, predominantly as patchy moderate staining within undifferentiated sarcoma. No cases showed SATB2 positivity in chondrosarcoma or rhabdomyosarcoma components. SATB2 is a highly sensitive marker for osteosarcomatous differentiation in gynecologic tract carcinosarcoma, and is also highly specific when used to differentiate osteosarcoma from chondrosarcoma and rhabdomyosarcoma elements in these tumors. However, a positive SATB2 result may lack specificity for differentiating osteosarcoma from an undifferentiated sarcoma component.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000301","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T16:28:46Z","timestamp":1465662526000},"page":"140-145","source":"Crossref","is-referenced-by-count":18,"title":["SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases"],"prefix":"10.1097","volume":"36","author":[{"given":"Ankur R.","family":"Sangoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malti","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Horvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres A.","family":"Roma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/dvdy.22483","article-title":"A cross-species analysis of Satb2 expression suggests deep conservation across vertebrate lineages","volume":"239","author":"Sheehan-Rooney","year":"2010","journal-title":"Dev Dyn"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/AJCPWW2URZ9JKQJU","article-title":"The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study","volume":"141","author":"Dragomir","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.5858\/arpa.2013-0452-OA","article-title":"Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine","volume":"138","author":"Lin","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/PAS.0b013e31821c3dae","article-title":"SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas","volume":"35","author":"Magnusson","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.anndiagpath.2015.05.004","article-title":"The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic","volume":"19","author":"Perez Montiel","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.34","article-title":"A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer","volume":"106","author":"Eberhard","year":"2012","journal-title":"Br J Cancer"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.2575","article-title":"Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer","volume":"219","author":"Wang","year":"2009","journal-title":"J Pathol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/embor.2010.125","article-title":"SATB2 augments DeltaNp63alpha in head and neck squamous cell carcinoma","volume":"11","author":"Chung","year":"2010","journal-title":"EMBO Rep"},{"key":"R9-20230824","first-page":"423","article-title":"Prognostic value of SATB2 expression in patients with esophageal squamous cell carcinoma","volume":"8","author":"Geng","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R10-20230824","first-page":"3710","article-title":"Decreased SATB2 expression is associated with metastasis and poor prognosis in human clear cell renal cell carcinoma","volume":"8","author":"Guo","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R11-20230824","first-page":"7072","article-title":"SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.12138","article-title":"SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours","volume":"63","author":"Conner","year":"2013","journal-title":"Histopathology"},{"key":"R13-20230824","article-title":"SATB2 expression is sensitive but may not be specific for osteosarcoma compared to other high-grade primary bone sarcomas","author":"Davis","year":"2015","journal-title":"Histopathology"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/PAS.0000000000000412","article-title":"Small cell osteosarcoma: clinicopathologic, immunohistochemical, and molecular analysis of 36 cases","volume":"39","author":"Righi","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0090-8258(89)90555-6","article-title":"Solid teratomas and mixed mullerian tumors of the ovary: a clinical, histological, and immunocytochemical comparative study","volume":"33","author":"Calame","year":"1989","journal-title":"Gynecol Oncol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(197101)27:1<207::AID-CNCR2820270129>3.0.CO;2-0","article-title":"Carcinosarcomas and mixed mesodermal tumors of the ovary","volume":"27","author":"Dehner","year":"1971","journal-title":"Cancer"},{"key":"R17-20230824","first-page":"720","article-title":"Malignant mixed mesodermal tumor of the ovary: a report of 22 cases","volume":"65","author":"Dictor","year":"1985","journal-title":"Obstet Gynecol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/PAS.0b013e3181161ba3","article-title":"Prognostic features of surgical stage I uterine carcinosarcoma","volume":"31","author":"Ferguson","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cncr.2820710440","article-title":"Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study","volume":"71","author":"Major","year":"1993","journal-title":"Cancer"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000478-197904000-00003","article-title":"Malignant mixed mullerian tumors of the uterus. A clinicopathologic assessment of 34 cases","volume":"3","author":"Barwick","year":"1979","journal-title":"Am J Surg Pathol"},{"key":"R22-20230824","first-page":"388","article-title":"Mixed mullerian tumors of the uterus: a clinicopathologic study","volume":"74","author":"Dinh","year":"1989","journal-title":"Obstet Gynecol"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0090-8258(85)90122-2","article-title":"Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus","volume":"20","author":"Macasaet","year":"1985","journal-title":"Gynecol Oncol"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/gyno.1997.4827","article-title":"Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study","volume":"67","author":"Sartori","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004347-199001000-00001","article-title":"Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases","volume":"9","author":"Silverberg","year":"1990","journal-title":"Int J Gynecol Pathol"},{"key":"R26-20230824","first-page":"920","article-title":"Primary ovarian sarcomas. Report of 43 cases from the Emil Novak Ovarian Tumor Registry","volume":"37","author":"Azoury","year":"1971","journal-title":"Obstet Gynecol"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00000478-198004010-00004","article-title":"Malignant mixed mesodermal tumors of the ovary: a clinicopathologic assessment of 12 cases","volume":"4","author":"Barwick","year":"1980","journal-title":"Am J Surg Pathol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.annonc.a059312","article-title":"Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients","volume":"6","author":"Chang","year":"1995","journal-title":"Ann Oncol"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.bjc.6600770","article-title":"Carcinosarcoma of the ovary","volume":"88","author":"Harris","year":"2003","journal-title":"Br J Cancer"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/COC.0b013e3182979b27","article-title":"Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy","volume":"38","author":"Pacaut","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"R31-20230824","first-page":"233","article-title":"Immunohistochemical study of osteonectin in various types of osteosarcoma","volume":"132","author":"Schulz","year":"1988","journal-title":"Am J Pathol"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s13277-011-0203-4","article-title":"Plasma membrane proteomic analysis of human osteosarcoma and osteoblastic cells: revealing NDRG1 as a marker for osteosarcoma","volume":"32","author":"Hua","year":"2011","journal-title":"Tumour Biol"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lfs.2012.10.021","article-title":"Cell adhesion molecule 1 is a new osteoblastic cell adhesion molecule and a diagnostic marker for osteosarcoma","volume":"92","author":"Inoue","year":"2013","journal-title":"Life Sci"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1471-2407-10-206","article-title":"Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines","volume":"10","author":"Zhang","year":"2010","journal-title":"BMC Cancer"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.humpath.2010.06.008","article-title":"Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors","volume":"41","author":"Dancer","year":"2010","journal-title":"Hum Pathol"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/030089169808400316","article-title":"Malignant mixed mullerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis","volume":"84","author":"Guarino","year":"1998","journal-title":"Tumori"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/gcc.20947","article-title":"Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?","volume":"51","author":"Chiyoda","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"R38-20230824","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semdp.2010.09.005","article-title":"Pathologic and molecular features of uterine carcinosarcomas","volume":"27","author":"Lopez-Garcia","year":"2010","journal-title":"Semin Diagn Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201703000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:25:38Z","timestamp":1692840338000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201703000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000301","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}